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NANOTECHNOLOGY PATENT LAW: A CASE STUDY OF 
UNITED STATES AND EUROPEAN PATENT 
APPLICATIONS 
By Michael Costello-Caulkins1 
As nanotechnology moves from research development to 
commercial development, applicants are seeking patents outside the 
United States and in European markets in greater numbers. As a 
consequence, understanding the challenges of international 
prosecution is of growing importance to nanotechnology companies. 
One way to understand these challenges is to look at how jurisdictions 
are treating patents. This article focuses on four case studies of 
nanotechnology patent applications filed in the United States and 
Europe. Ultimately, the European applications were abandoned 
earlier in prosecution and in greater numbers than the US applications 
and, where patents issued in both jurisdictions, the European patents 
contained narrower claims. This is attributable to different prior art 
relied on by the European Patent Office, which read on more claims 
and required additional claim limitations than the US prior art. To 
provide context to the case study a definition of nanotechnology, a 
comparison of the patent laws, and a summary of previous scholarship 







1  JD Candidate, Santa Clara University School of Law, 2021. The author 
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INTRODUCTION 
Nanotechnology has become increasingly relevant across a wide 
range of fields.2 For example, nanotechnology is critical to the mRNA 
COVID-19 vaccine developed by Moderna, Inc.3 The mRNA 
technology “employs nanoparticles-based drug release approaches”4 
that allow for improved penetration into tissues and low toxicity to the 
body.5 Additionally, major manufacturing hurdles have been overcome 
in the creation of a 16-bit microprocessor comprising carbon nanotube 
transistors which are ten times as energy efficient as silicon transistors.6 
It is safe to say that nanotechnology is a rapidly growing technological 
area. As a result, there are a growing number of patent applications 
being filed.7  
In 2020, about three percent of the total patent applications filed at 
the United States Patent and Trademark Office (“USPTO”) and the 
European Patent Office (“EPO”) were related to nanotechnology.8 In 
terms of granted patents and published patent applications, a total of 
22,462 and 5,292 nanotechnology patents were issued by the USPTO 
and EPO respectively.9 The EPO’s nanotechnology patents account for 
23.6% of the USPTO’s patents, showing a sizable increase compared 
to 2016 (i.e., 18%).10 This growth reveals “the considerable attention 
of countries and companies all over the world to the EU’s 
nanotechnology markets compared to the US ones.”11  
 
2 Benefits and Applications, NANO.GOV: NATIONAL NANOTECHNOLOGY 
INITIATIVE, https://www.nano.gov/you/nanotechnology-benefits. 
3 Technology Against COVID-19: Nano Insights into Prevention, Diagnosis, 
and Treatment, STATNANO, https://statnano.com/technology-against-covid-
19-nano-insights.  
4 Id.  
5 Lipid Nanoparticles, PRECISION NANOSYSTEMS, 
https://www.precisionnanosystems.com/workflows/formulations/lipid-
nanoparticles.  
6 Becky Ham, Carbon nanotube transistors make the leap from lab to factory 
floor, MIT NEWS: ON CAMPUS AND AROUND THE WORLD (June 1, 2020), 
https://news.mit.edu/2020/carbon-nanotube-transistors-factory-0601.  
7 A Statistical Look at USPTO Nanotechnology Patents Published in 2020, 
STATNANO (Jan. 26, 2021), https://statnano.com/news/68609/A-Statistical-
Look-at-USPTO-Nanotechnology-Patents-Published-in-2020. 
8 Id.  
9 2020’s Statistical Review of Top Countries in Holding Nanotechnology 
Patents, STATNANO (Feb. 1, 2021), https://statnano.com/news/68635/2020’s-
Statistical-Review-of-Top-Countries-in-Holding-Nanotechnology-Patents.  
10 Id.  
11 Id. 
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As the EU’s nanotechnology market continues to grow, it is 
important for US companies considering patent protection in Europe to 
understand the challenges of pursuing an international patent portfolio. 
To highlight how European patent law differs from United States law 
in regard to nanotechnology, this paper presents four case studies of 
nanotechnology patent applications. More specifically, I identify four 
pairs of “matched USPTO-EPO patent application twins”12 and analyze 
their prosecution histories. Each of the pairs refers to early 
nanotechnology patents that sought to protect the basic ideas of the 
technology,13 which highlight some of the issues unique to the field. To 
the same end, this article presents a definition of nanotechnology, a 
comparison of US and European patent law, and a summary of the 
relevant scholarship.  
Based on the EPO’s greater understanding of the issues affecting 
nanotechnology patents and better reputation, I hypothesize that the 
European patent applications will issue into patents at a lower rate than 
the US applications and contain narrower claims. The results of the four 
case studies largely confirm my hypothesis. I find that it is much harder 
to get a nanotechnology patent in Europe than it is in the US, in part, 
because the EPO relies on better prior art than the USPTO.   
I. DEFINING NANOTECHNOLOGY 
 Nanotechnology involves science at the nanometer scale.14 A 
nanometer is a unit of measure that is one billionth of a meter and 
materials at this size have unique properties that are governed less by 
the traditional laws of physics and more by the behavior of individual 
atoms and molecules.15 This can be quite different than the behavior 
exhibited by the same material in bulk. For instance, aluminum in bulk 
is stable but at the nanoscale it is combustible.16 Gold also undergoes a 
 
12 Colleen Chien, Comparative Patent Quality, 50 ARIZ. ST. L.J. 71, 102 
(2018). 
13 See discussion infra Section IV. 
14 What It Is and How It Works, NANO.GOV: NATIONAL NANOTECHNOLOGY 
INITIATIVE, https://www.nano.gov/nanotech-101/what. 
15 Mark A. Lemley, Patenting Nanotechnology, 58 STAN. L. REV. 601, 602 
(2005) (discussing how the characteristics of nanoscale materials lie “between 
the classical large-molecule level to which traditional physics and chemistry 
apply and the atomic level in which the bizarre rules of quantum mechanics 
take effect”); Ten Things You Should Know About Nanotechnology, 
NANOWERK, 
https://www.nanowerk.com/nanotechnology/ten_things_you_should_know_
3.php [hereinafter Ten Things].  
16 Ten Things, supra note 15.  
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transformation as it gets smaller and smaller, eventually turning to 
liquid at room temperature.17  
Patent offices have defined nanotechnology accordingly. Both 
the USPTO and EPO have designated nanotechnology with its own 
class designation: class 977 and B82Y, respectively.18 With regard to 
size, the USPTO defines a nanostructure as having at least one physical 
dimension of approximately 1-100 nanometers.19 Similarly, the EPO 
states that a nanostructure must have “at least one nanosized functional 
component,” where “nanosized” relates to a dimension below 100 
nanometers.20 With regard to properties, both offices state in similar 
terms that the nanostructure must have a special property that is 
uniquely attributable to the nanoscale.21  
II. UNITED STATES & EUROPEAN PATENT SYSTEMS 
Before looking at the data, it is important to understand the 
patent system in each region. Specifically, it is important to understand 
the difference in legal standards and evidentiary processes, with a focus 
on which regime encourages a more rigorous examination. This paper 
touches on provisions that were particularly relevant in the prosecution 
of these patents: novelty and non-obviousness. It is worth noting the 
patents in this paper were all filed before March 16, 2013, so the pre-
AIA provisions of the US Code are applicable.  
A. Novelty 
With regard to novelty, 35 US Code Section 102 governs, and 
section (a) says that an invention is not novel if it is known or used in 
the US, or if it is published anywhere in the US or a foreign country.22 
Case law has defined a published reference as one that has been 
disseminated or made available so persons interested and ordinarily 
skilled in the subject matter can locate it.23 Case law has also defined 
 
17 Id.  
18 Class 977 Nanotechnology, USPTO, 
https://www.uspto.gov/web/patents/classification/uspc977/defs977.htm 
[hereinafter USPTO]; Nanotechnology, EUROPEAN PATENT OFFICE: NEWS & 
EVENTS, https://www.epo.org/news-events/in-
focus/classification/nanotechnology.html. 
19 USPTO, supra note 18. 
20 COOPERATIVE PATENT CLASSIFICATION, DEFINITION: B82Y (2017).  
21 Id.; USPTO, supra note 18.  
22 Melanie J. Howlett & Andrew F. Christie, An Analysis of the Approach of 
the European, Japanese and United States Patent Office to Patenting Partial 
DNA Sequences (ESTS), 34 INT’L REV. INDUS. PROP. & COPYRIGHT 581, 591 
(2003).  
23 Id.  
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“known or used” as that which is accessible to the public, with no 
deliberate attempt to keep it secret.24  
In Europe, novelty is governed by Article 54 of the European 
Patent Convention (“EPC”).25 Article 54 mandates that “an invention 
shall be considered to be new if it does not form part of the state of the 
art.”26 The state of the art comprises “everything made available to the 
public by means of a written or oral description, by use or in any other 
way, before the date of the filing of the European patent application.”27 
Lack of novelty can be evident from explicit statements in the 
document, or it can be implicit, “such that a skilled person would 
inevitably arrive at the claimed invention by following the teaching of 
the prior document.”28  
In practice, there are two key differences between the novelty 
requirements. First, Europe follows the principle of absolute novelty, 
meaning a patent application must be filed before the occurrence of any 
activity that would constitute prior art.29 In the US, there is a one-year 
grace period from initial public disclosure or commercial use in which 
an inventor can file a patent application and still obtain a valid patent.30 
Second, Europe follows a policy of qualified public use, where the 
public disclosure actually has to enable someone to figure out what the 
invention is.31 In the US, neither public disclosure nor commercial use 
has to be enabling.32  
B. Non-obviousness 
In the US, non-obviousness is covered in 35 US Code Section 
103.33 Section 103 states that a patent will be rejected when the 
collective prior art suggests to a person skilled in the art that the 
patent’s claim was obvious.34 Non-obviousness analysis is fact 
dependent and requires comparing the claimed subject matter as a 
 
24 Id.      
25 European Patent Convention art. 54, Oct. 5, 1973, 1065 U.N.T.S. 272. 
26 Id.  
27 Id.  
28 Howlett & Christie, supra note 22, at 588.   
29 Jeffrey M. Kaden, Patent Protection and the Novelty Requirement, 
GOTTLIEB, RACKMAN & REISMAN, P.C., https://grr.com/publications/patent-
protection-novelty-requirement/.  
30 Id.  
31 Andre Marais, Schwegman Lundberg & Woessner, US vs EP Patent 
Consideration: A Practical Guide to the Differences, Presentation at Santa 
Clara School of Law (Oct. 6, 2020).  
32 Id.  
33 35 U.S.C. § 102 (2015). 
34  Id.  
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whole to the prior art.35 To establish a prima facie case of obviousness 
an examiner can show three things: (1) a suggestion or motivation in 
the prior art to modify the reference; (2) a reasonable expectation of 
success in combining or modifying the prior art to arrive at the claimed 
invention; and (3) prior art references that suggest all of the claim 
limitations.36 Importantly, obviousness is judged by the hypothetical 
person of ordinary skill right before the invention was made.37  
Under the EPC, Article 56 states that an invention has an 
inventive step, if “having regard to the state of the art, it is not obvious 
to a person skilled in the art.”38 This is evaluated using a “problem-
solution” approach which involves three steps: (1) determining the 
closest prior art; (2) establishing the technical problem to be solved in 
the present application; and (3) considering whether the present 
invention, beginning with the closest prior art and the technical 
problem, would have been obvious to a person skilled in the art.39 
Obvious is defined as “not going beyond the normal progress of 
technology but rather following plainly or logically from that prior 
art.”40 Importantly, the closest prior art must be in the same technical 
field and must address the same problem as the present invention.41 
In practice, the European “problem-solution” approach 
requires an examiner to strike out all non-technical language in the 
claims and any claim element that appears in the prior art.42 If what 
remains is a technical solution to a technical problem, an inventive step 
exists.43 This inquiry resembles an eligible subject matter evaluation 
and is quite different than the US approach, which focuses primarily 
on whether the combination of prior art is obvious and contains every 
claim element.44   
 
 
35 Howlett & Christie, supra note 22, at 592.   
36 Id.  
37 Id.; Tom Irving, Obviousness: Overcoming Obviousness Rejections by 
Attacking the Prima Facie Case, LEXIS PRACTICE ADVISOR 2, 
https://www.finnegan.com/images/content/2/5/v2/255327/PUBLISHED-
Lexis-Practice-Advisor-Obviousness-Overcoming-Obvi.pdf.  
38 European Patent Convention art. 56, Oct. 5, 1973, 1065 U.N.T.S. 273. 
39 Howlett & Christie, supra note 22, at 589.   
40 Id. at 590. 
41 Id. at 589–90.  
42 Andre Marais, Schwegman Lundberg & Woessner, US vs EP Patent 
Consideration: A Practical Guide to the Differences, Presentation at Santa 
Clara University School of Law (Oct. 6, 2020).  
43 Id.  
44 Id.  
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III. RELEVANT SCHOLARSHIP 
There are a couple areas of patent scholarship that are 
applicable to this case study. The first has to do with patenting 
nanotechnology and the second, more generally, compares obtaining 
patent rights in the US and Europe. Scholarship on patenting 
nanotechnology tends to be region specific, with the exception of a 
single case study that compared the prosecution of a nanotechnology 
patent application in the US and Europe.45 This section briefly 
summarizes the prior art and provides a prediction about the results of 
this case study.  
The first area of relevant patent scholarship looks at 
nanotechnology patents. Most authors focus on subject matter of early 
nano patents, the cross disciplinary nature of nano patents,46 and 
novelty concerns with miniaturizing prior inventions.47 In both the US 
and Europe, the basic ideas, or “building blocks,” of nanotechnology 
were patented.48 For example, in the US, patents have issued on carbon 
nanotubes, semiconducting and light emitting nanocrystals, nanorods, 
and methods for making nanotubes and nanocrystals.49 This is the first 
area of technology in almost one hundred years in which the building 
 
45 Luca Escoffier, Nanotechnology Under the Magnifying Lens from a 
European and U.S. Perspective: General Patent Statistics, Non-Obviousness 
Versus Inventive Step, and Two Case Studies in CNT Commercialization 
(Stanford – Vienna Transatlantic Technology Law Forum Working Paper 
Series, Paper No. 3, 2009), https://law.stanford.edu/wp-
content/uploads/sites/default/files/publication/205107/doc/slspublic/escoffier
_wp3.pdf. 
46 For scholarship on the subject matter and cross disciplinary nature of nano 
patents see Lemley, supra note 15, at 606–14; Amit Makker, The 
Nanotechnology Patent Thicket and the Path to Commercialization, 84 S. 
CAL. L. REV. 1163 (2011); Maurice H.M. Schellekens, Patenting 
Nanotechnology in Europe: Making a Good Start? An Analysis of Issues in 
Law and Regulation, 9 (TILT Law & Tech., Working Paper No. 008/2008, 
2008), https://papers.ssrn.com/sol3/papers.cfm?abstract_id=1139080. 
47 See Emily M. Morris, The Irrelevance of Nanotechnology Patents, 49 CONN. 
L. REV. 499 (Dec. 2016); Jordan Paradise, Claiming Nanotechnology: 
Improving USPTO Efforts at Classification of Emerging Nano-Enabled 
Pharmaceutical Technologies, 10 NW. J. TECH. & INTELL. PROP. 169, 175 
(2012); Andrew Wasson, Protecting the Next Small Thing: Nanotechnology 
and the Reverse Doctrine of Equivalent, 2004 DUKE L. & TECH. REV. 10 
(2004); Christopher Anderson, Small Can be Inventive: The Patentability of 
Nanoscale Reproductions of Macroscale Machines, 9 Wm. & Mary Bus. L. 
Rev. 295 (Nov. 2017).  
48 Lemley, supra note 15, at 606–14. 
49 Id.  
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blocks were patented from the beginning.50 In fields like computer 
hardware, the internet, and biotechnology, early research was 
conducted by the US government or the US government compelled 
companies and universities to license their patents.51 Nanotechnology 
has not been subject to the same government-mandated licenses or 
policies against university patenting and, as a result, patenting occurred 
early.52 The European Commission has expressed concern that 
“nanotechnology is raising fundamental questions as to what should, 
and should not be patentable, e.g., on the level of individual 
molecules.”53 Additionally, the EPO has worked on instruments to 
monitor nanotechnology patents to prevent over patenting.54  
Scholarship also focuses on the cross-disciplinary structure of 
nanotechnology.55 Particularly, patents on the basic ideas can affect 
multiple fields ranging from biomedicine to telecommunications.56 
Patentees will consequently have rights in several industries, and 
expertise in each industry will be required to commercialize each 
patent.57 This has raised practical concerns in Europe such as what 
disciplines should the person skilled in the art have.58 One commentator 
has suggested defining a person skilled in the art as a team of people, 
each skilled in a discipline that could be used by the invention.59  
Nanotechnology patents also raise the unique issue whether 
macroscale devices can be prior art for nanoscale inventions. When 
considered broadly, courts have found that a patent covers the same 
invention independent of its size.60 But nanotechnology is 
fundamentally different in that its material properties are not present at 
the macroscale.61 One case in particular has dealt with issues regarding 
the size range of nanotechnology, finding that a nanotechnology patent 
can infringe a non-nanotechnology patent where the two patents 
 
50 Id.  
51 Id.  
52 Id.  
53 Schellekens, supra note 46. 
54 Id. at 7. 
55 See Lemley, supra note 15, at 614; Makker, supra note 46; Schellekens, 
supra note 46.  
56 Lemley, supra note 15. 
57 Makker, supra note 46, at 1173. 
58 Schellekens, supra note 46.  
59 Id.  
60 Anderson, supra note 47, at 287. 
61 Id.  
346 SANTA CLARA HIGH TECH. L.J.  [Vol. 37 
specify particles with overlapping size ranges.62 In contrast, when 
faced with situations where a nano-patent overlaps with ranges 
mentioned in the prior art, the EPO’s Technical Board of Appeal has 
noted that the prior art was not novelty destroying because the prior art 
did not provide specific examples in the overlapping part of the range.63  
One case study has compared the prosecution of a 
nanotechnology patent in the US and Europe.64 The patent pertained to 
patterning carbon nanotubes and was subject to two office actions in 
the US where the examiner had the applicant restrict the patent to one 
of two enclosed inventions and make minor formal amendments to the 
application.65 The applicant submitted a supplemental European search 
report to the examiner, which was acknowledged, but had no effect on 
the outcome of the application.66 The application eventually issued as 
a patent.67 In Europe, the application was found to lack novelty and 
inventive step based on two patents that were cited references in the 
US patent.68 The applicants slightly amended the claims but after the 
EPO considered a new, non-patent reference relevant, that was cited in 
the supplemental European search report, the application was 
abandoned.69 The author concluded the case study “exemplifies how 
cumbersome an international prosecution can be.”70  
More generally, the EPO has long held a reputation as the 
“gold standard” among patent offices in terms of patent quality.71 This 
is because the EPO makes upfront investment in prosecution, regularly 
relies on non-patent references, and caps application continuations 
following rejections.72 By contrast, the USPTO is not held in as high 
regard in terms of patent quality, in part, because their continuation 
policy allows applicants to continue prosecuting applications despite 
final rejection.73 The USPTO also falls behind the EPO in several key 
metrics. For example, the EPO spends thirty hours examining a patent 
 
62 Paradise, supra note 47 (discussing Elan Pharma Int’l Ltd. v. Abraxis 
Bioscience Inc., No. 06-438 GMS, 2007 WL 6382930 (D. Del. Dec. 17, 
2007)).  
63 Schellekens, supra note 46.  
64 Escoffier, supra note 45. 
65 Id. at 28.  
66 Id. at 29.  
67 Id.  
68 Id.   
69 Id. at 30. 
70 Escoffier, supra note 45, at 30. 
71 Chien, supra note 12, at 74.  
72 Id. at 101–20.  
73 Id. at 106. 
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compared to the USPTO’s thirteen hours.74 Additionally, the EPO 
typically applies a team of three examiners to a patent, whereas the 
USPTO applies one primary examiner.75 In sum, the EPO invests 
heavily in getting patent quality right at early stages of prosecution, 
which, not surprisingly, leads to higher rates of abandonment when 
compared to the USPTO.76  
For several reasons, the US patent applications in this case 
study should issue into patents at a higher rate than the European 
applications, and in cases where applications issue in both jurisdictions, 
contain broader claims. The EPO not only appears to have a greater 
understanding of the unique issues affecting nanotechnology patents,77 
but their reputation as a better patent office78 would make it more 
difficult for applicants to obtain a patent. Additionally, the previous 
nano patent case study suggests that nano patents are more difficult to 
obtain in Europe than in the US.79  
IV. THE CASE STUDY  
Comparative studies of patent law are not new. Many studies 
have been done comparing the law between regions,80 but few studies 
have been conducted at the case study level. In addition, 
nanotechnology has been studied for a long time,81 but the study of 
nanotechnology patents is less prevalent. To understand the differences 
in patent law between the US and Europe with respect to 
nanotechnology, this section analyzes four pairs of nanotechnology 
patent applications. I initially searched for “building-block” patents 
 
74 Id. at 111. 
75 Id.  
76 Id. at 107. 
77 Schellekens, supra note 46, at 7, 9.  
78 Chien, supra note 12, at 74.  
79 Escoffier, supra note 45, at 30. 
80 Chien, supra note 12; Paul H. Jensen et al., Disharmony in International 
Patent Office Decisions, 15 FED. CIR.B.J. 679, 679–82 (2006); Alfons 
Palangkaraya et al., Misclassification Between Patent Offices: Evidence from 
a Matched Sample of Patent Applications, 93 REV. ECON. & STAT. 1063, 
1063–64 (2011); Elizabeth Webster et al., Characteristics of International 
Patent Application Outcomes, 95 ECON. LETTERS 362, 367–68 (2007). 
81 See Samer Bayda et al., The History of Nanoscience and Nanotechnology: 
From Chemical-Physical Applications to Nanomedicine, MOLECULES (Dec. 
27, 2019), https://www.mdpi.com/1420-3049/25/1/112 (Richard Feynman 
introduced the concept of nanotechnology in 1959 during the annual meeting 
of the American Physical Society).  
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and found ten,82 however, only three had European counterparts and, 
of those three, only two had US file wrappers that were published 
online.83 To find a larger sample of accessible EPO/USPTO patent 
applications, I searched for similar applications using Google Patents 
and identified nine matched pairs of EPO/USPTO patent 
applications.84 Notably, five of these pairs contained abandoned 
European patent applications,85 and one contained an abandoned US 
application.86 For this study, I selected one of the pairs containing an 
abandoned European application,87 the one pair containing an 
abandoned US application,88 and one pair where both the US and 
European applications issued into patents.89 In summary, these 
applications cover fundamental nanotechnology inventions chosen for 
their significance in the field, in addition to the fact that patent 
protection was sought both in the US and Europe.  
A. Case 1: US 7,425,368 & WO 2006/023697 
US patent 7,425,368 started as a provisional application filed 
on August 20, 2004.90 The invention contained 19 claims and described 
a polymer infused with nano particles which created a fiber with 
 
82 Lemley, supra note 15, at 613–14 (citing ten patents on the basic ideas in 
nanotechnology like carbon nanotubes, semiconducting nanocrystals, and 
metal oxide nanorods). 
83 Patent applications filed before June 20, 2003, were not scanned into the 
Image File Wrapper system and so were not available online in public PAIR 
after they published. MPEP § 1730 (II)(B)(1)(d) (8th ed. Rev. 7, Sept. 2008). 
84 The nine US patent applications identified using Google Patents include 
U.S. Patent Application Serial No. 11/179,102 (filed July 15, 2005); U.S. 
Patent Application Serial No. 10/470,517 (filed July 29, 2003); U.S. Patent 
Application Serial No. 10/090,223 (filed Mar. 4, 2002); U.S. Patent 
Application Serial No. 10/549,950 (filed Mar. 19, 2004); U.S. Patent 
Application Serial No. 10/976,179 (filed Oct. 29, 2004); U.S. Patent 
Application Serial No.10/977,363 (filed Oct. 29, 2004); U.S. Patent 
Application Serial No. 11/120,729 (file May 3, 2005); U.S. Patent Application 
Serial No. 13/392,124 (filed Aug. 25, 2010); U.S. Patent Application Serial 
No. 09/133.948 (filed Aug. 14, 1998).  
85 U.S. Patent Application Serial No. 11/179,102 (filed July 15, 2005); U.S. 
Patent Application Serial No. 10/470,517 (filed July 29, 2003); U.S. Patent 
Application Serial No. 10/549,950 (filed Mar. 19, 2004); U.S. Patent 
Application Serial No. 11/120,729 (file May 3, 2005); U.S. Patent Application 
Serial No. 09/133.948 (filed Aug. 14, 1998).  
86 U.S. Patent Application Serial No. 13/392,124 (filed Aug. 25, 2010). 
87 U.S. Patent Application Serial No. 11/179,102 (filed July 15, 2005). 
88 U.S. Patent Application Serial No. 13/392,124 (filed Aug. 25, 2010). 
89 U.S. Patent Application Serial No.10/977,363 (filed Oct. 29, 2004). 
90 U.S. Patent No. 7,425,368 at [22].  
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improved axial strength.91 On December 14, 2007, the USPTO required 
the patent to be restricted to one of the two inventions enclosed.92 
Specifically, claims 1-14 of the application were drawn to the fiber, 
while claims 15-19 were drawn to a method for making the fiber.93 On 
January 18, 2008, the applicants replied electing to restrict the 
invention to the claims drawn to the fiber.94  
On January 31, 2008, the USPTO sent an Office Action 
concerning the restricted claims.95 According to the USPTO, claims 1-
4 and 6-14 were indefinite and claims 1-4, 6, 8-9, and 13-14 lacked 
novelty pursuant to US Code Section 102.96 On April 21, 2008, the 
applicants replied by amending claim 1, cancelling claims 4, 10, 12, 
and 14, and rewriting claim 11 in independent form.97 On September 
5, 2008, the USPTO sent a notice of allowance stating that the amended 
application was acceptable,98 and on September 16, 2008, a patent was 
issued.99  
The applicants also filed a PCT application on August 19, 
2005.100 The EPO conducted an international prior art search which 
published on February 3, 2006.101 A year later, an international 
preliminary report on patentability indicated claims 1-14 lacked 
novelty and an inventive step.102 The last document available shows 
 
91 U.S. Patent Application Serial No. 11/179,102 (filed July 15, 2005). 
92 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 11179102, REQUIREMENT 
FOR RESTRICTION/ELECTION (Dec. 14, 2007). 
93 Id.  
94 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 11179102, 
AMENDMENT/REQUEST FOR RECONSIDERATION AFTER NONFINAL REJECTION 
(Jan. 18, 2008). 
95 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 11179102, NONFINAL 
REJECTION (Jan. 31, 2008). 
96 Id.  
97 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 11179102, APPLICANT 
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (Apr. 21, 2008). 
98 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 11179102, NOTICE OF 
ALLOWANCE AND FEES DUE (Sept. 5, 2008). 
99 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 11179102, ISSUE 
NOTIFICATION (Sept. 16, 2008). 
100 World Intellectual Property Organization (WIPO), Filler-Enhanced 
Polymeric Fibers with Improved Mechanical Properties and Method for 
Making, WO 2006/034697 (filed on Aug. 19, 2005). 
101 European Patent Office (EPO), International Search Report, File No. 
05791549.8 (Feb. 3, 2006). 
102 Id. 
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that in April 2007, the EPO sent a notice announcing the loss of rights 
due to lack of payment.103 
To summarize, the US application issued into a patent104 and 
the EU application was abandoned.105 There were several differences 
between the prosecution of the two applications. The first is that the 
USPTO relied exclusively on US patent material,106 while the EPO 
relied on a combination of US and foreign patent material.107 Notably, 
shown in Table 1, none of the references relied on by the patent 
offices overlapped. This had a big impact on the perceived validity of 
the applications.  
 
Table 1: References Cited by the USPTO108 and EPO109 
For example, in the US, the examiner stated the fiber disclosed 
in US-2005/0049355 possessed the same enhanced mechanical 
properties as the fiber disclosed in nine of the applicant’s claims.110 In 
 
103 European Patent Office (EPO), Application Deemed to be Withdrawn, File 
No. 05791549.8 (Apr. 27, 2007). 
104 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 11179102, ISSUE 
NOTIFICATION (Sept. 16, 2008). 
105 European Patent Office (EPO), Application Deemed to be Withdrawn, File 
No. 05791549.8 (Apr. 27, 2007). 
106 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 11179102, LIST OF 
REFERENCES CITED BY APPLICANT AND CONSIDERED BY EXAMINER (Jan. 29, 
2008); U.S. PATENT & TRADEMARK OFFICE, FILE NO. 11179102, LIST OF 
REFERENCES CITED BY EXAMINER (Jan. 31, 2008). 
107 European Patent Office (EPO), International Search Report, File No. 
05791549.8 (Feb. 3, 2006). 
108 LIST OF REFERENCES CITED BY APPLICANT, supra note 106; LIST OF 
REFERENCES CITED BY EXAMINER, supra note 106. 
109 International Search Report, supra note 107.  
110 NONFINAL REJECTION, supra note 95.  
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response, the applicant’s amended independent claim 1 to specify a 
unique structural identity and composition, shown in Table 2.111  
Claim 1: Amended 
Filler-enhanced polymeric fiber comprising: 
a polymer fiber: and 
high aspect ratio filler particles dispersed within the polymeric fiber 
and in intimate contact during processing with the polymeric fiber, 
the filler particles, having an interfiber spacing of less than 350 
nanometers, serving as templates to orient the molecular structure of 
the polymer fiber to enhance fiber mechanical properties.112    
Table 2: Amendments to Claim 1 of the US Application 
In contrast, the EPO found that WO-03/020638 disclosed 
essentially the same fiber disclosed in claim 1 of the application.113 The 
EPO went on to indicate the remaining thirteen dependent claims did 
not contain features that imparted novelty or an inventive step.114  
Ultimately, the different references led the USPTO and EPO 
to different conclusions about the applications. The EPO indicated 
early in prosecution that every claim directed to the fiber either lacked 
novelty or an inventive step, limiting the applicant’s path forward.115 
Relying on a different set of references, the USPTO indicated some, 
but not all, of the claims in the application were obvious, allowing the 
applicants to cure their claims through amendment.116  
B. Case 2: US 7,465,871 & EP 1,812,974 
US Patent 7,465,871 started as a patent application filed on 
October 29, 2004.117 The application consisted of 65 claims that were 
directed towards a composite made of a semiconductor material 
infused with nanoparticles.118 On December 2, 2005, the USPTO sent 
a notice requiring applicants to restrict the invention to one of two 
 
111 APPLICANT ARGUMENTS/REMARKS MADE IN AN AMENDMENT, supra note 
97. 
112 Id.  
113 European Patent Office (EPO), Copy of the International Preliminary 
Report on Patentability, File No. 05800694.1 (Apr. 3, 2007). 
114 Id.  
115 Id.  
116 APPLICANT ARGUMENTS/REMARKS MADE IN AN AMENDMENT, supra note 
97. 
117 U.S. Patent No. 7,465,871 at [22] (filed Oct. 29, 2004). 
118 U.S. Patent Application Serial No. 10/977,363 (filed Oct. 29, 2004). 
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inventions enclosed in the patent.119 The USPTO stated that claims 1-
56 were drawn to the composite material, while claims 57-65 were 
drawn to a method of manufacturing the composite.120 On January 27, 
2006, the applicants replied electing to restrict the invention to the 
composite.121  
On May 23, 2006, the USPTO sent an Office Action 
concerning the remaining claims.122 The USPTO found that certain 
claims were not novel, and a combination of references rendered 
additional claims obvious.123 On September 22, 2006, the applicants 
replied amending claims 1, 32, 38, 41, 53, 56, and adding a new 
claim.124 On June 1, 2007, the USPTO sent a second Office Action 
stating claims 1-11, 15-25, 27-31, 38-43, 52, 53, 56, and 66 were not 
novel in light of new prior art.125 On October 10, 2007, the applicants 
replied with a declaration that one of the references was authored by 
the co-inventors,126 prompting the USPTO to withdraw their rejection 
of claims 15-16, 22, 24-25, 27-28, 52-53, and 66.127  
On April 8, 2008, the applicants amended claim 1, canceled 
claims 38-43 and 56, and added claims 70-160.128 On June 18, 2008, 
the USPTO withdrew their rejection of claim 1 but rejected claims 106-
109, 128-131, 139-142, and 150-153.129 On July 3, 2008, the applicants 
replied cancelling the rejected claims.130 On October 10, 2008, the 
 
119 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, REQUIREMENT 
FOR RESTRICTION/ELECTION (Dec. 2, 2005). 
120 Id.  
121 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, 
AMENDMENT/REQUEST FOR RECONSIDERATION AFTER NONFINAL REJECTION 
(Jan. 27, 2006). 
122 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, NONFINAL 
REJECTION (May 23, 2006). 
123 Id.  
124 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, APPLICANT 
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (Sept. 22, 2006). 
125 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, NONFINAL 
REJECTION (June 1, 2007). 
126 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, APPLICANT 
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (Oct. 10, 2007). 
127 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, FINAL 
REJECTION (Dec. 27, 2007).  
128 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, APPLICANT 
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (Apr. 8, 2008).  
129 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, NONFINAL 
REJECTION (June 18, 2008). 
130 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, APPLICANT 
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (July 3, 2008). 
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USPTO sent a notice of allowance and on December 16, 2008 a patent 
was issued.131  
The applicants also filed a PCT application on October 31, 
2005.132 The EPO conducted an international prior art search which 
published on May 16, 2007.133 An IPR followed on February 12, 2008, 
indicating the claims defined three different inventions and that claims 
1-15, 20-30, and 37-41 were not novel.134 On June 24, 2009, the 
applicants replied electing to restrict the application to one of the 
inventions, and amended claim 1.135 On February 14, 2014, the EPO 
sent a notice that the application still was not in conformity with the 
EPC.136 On June 16, 2014, the applicants replied with a second 
amendment to claim 1 and canceled another claim.137 Satisfied with the 
applicant’s amendments, the EPO issued a patent on July 16, 2015.138  
To summarize, both applications issued into patents.139 The 
USPTO relied on a combination of US patent material and non-patent 
references,140 whereas the EPO relied on US and foreign patent 
material and non-patent references.141 Notably, three of the references 
 
131 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, ISSUE 
NOTIFICATION (Dec. 16, 2008). 
132 World Intellectual Property Organization (WIPO), Nanocomposites with 
High Termoelectric Figures of Merit, WO 2006/127923 (filed on Oct. 31, 
2005). 
133 European Patent Office (EPO), Copy of the International Search Report, 
File No. 05858279.2 (May 16, 2007). 
134 European Patent Office (EPO), Copy of the International Preliminary 
Report on Patentability, File No. 05858279.2 (Feb. 12, 2008). 
135 European Patent Office (EPO), Reply to Communication from the 
Examining Division, File No. 05858279.2 (June 24, 2009). 
136 European Patent Office (EPO), Communication from the Examining 
Division, File No. 05858279.2 (Feb. 14, 2014). 
137 European Patent Office (EPO), Reply to Communication from the 
Examining Division, File No. 05858279.2 (June 16, 2014). 
138 European Patent Office (EPO), Communication About Intention to Grant a 
European Patent, File No. 05858279.2 (Nov. 4, 2014).  
139 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, ISSUE 
NOTIFICATION (Dec. 16, 2008); European Patent Office (EPO), 
Communication About Intention to Grant a European Patent, File No. 
05858279.2 (Nov. 4, 2014).  
140 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, LIST OF 
REFERENCES CITED BY EXAMINER (May 23, 2006); U.S. PATENT & 
TRADEMARK OFFICE, FILE NO. 10977363, LIST OF REFERENCES CITED BY 
EXAMINER (June 1, 2007); U.S. PATENT & TRADEMARK OFFICE, FILE NO. 
10977363, LIST OF REFERENCES CITED BY EXAMINER (Dec. 27, 2007). 
141 European Patent Office (EPO), Copy of the International Search Report, 
File No. 05858279.2 (May 16, 2007). 
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relied on by the patent offices overlapped, shown in Table 3. This led 
the applicants to pursue similar prosecution strategies in both 
jurisdictions.  
 
Table 3: References Cited by the USPTO142 and EPO143 
For example, both patent offices rejected independent claim 1 
in view of US-2003/0099279.144 In response, the applicants amended 
claim 1 by adding that the nano particles were dispersed randomly 








142 LIST OF REFERENCES CITED BY EXAMINER (May 23, 2006), supra note 140; 
LIST OF REFERENCES CITED BY EXAMINER (June 1, 2007), supra note 140; 
LIST OF REFERENCES CITED BY EXAMINER (Dec. 27, 2007), supra note 140. 
143 Copy of the International Search Report, supra note 141.  
144 NONFINAL REJECTION, supra note 122; European Patent Office (EPO), 
Communication from the Examining Division, File No. 05858279.2 (Feb. 13, 
2009). 
145 APPLICANT ARGUMENTS/REMARKS MADE IN AN AMENDMENT, supra note 
124; Reply to Communication from the Examining Division, supra note 135.  
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US Claim 1: Amended EU Claim 1: Amended 
A thermoelectric 
nanocomposite semiconductor 
composition, comprising: a 
semiconductor host material, 
and a plurality of nano-sized 
inclusions distributed randomly 
within said host material, said 
inclusions being formed of a 
semiconductor inclusion 
material, wherein said host 
material comprises dopants, 
and wherein the conduction 
band-edge offset or a valence 
band-edge offset between said 
host material and the inclusion 
material at an interface of the 
two materials is less than about 
5kT,wherein k is the Boltzman 
constant and T is an average 





composition, comprising: a 
semiconductor host material, 
and a plurality of nano-sized 
inclusions distributed randomly 
within said host material, said 
inclusions being formed of a 
semiconductor inclusion 
material, wherein the host 
material comprises a plurality 
of nano-sized structures formed 
of a semiconductor material 
different than said 
semiconductor inclusion 
material, and wherein the 
conduction bad-edge offset or a 
valence band-edge offset 
between said host material and 
the inclusion material at an 
interface of the two materials is 
less than about 5kbT, where kb 
is the Boltzman constant and T 
is an average temperature of 
said nanocomposite 
composition.147 
Table 4: Amendments Made to the US and EU Applications 
The additional amendments in the EU application were 
prompted by US-2003/0099279 and two non-patent references unique 
to the EU prosecution.148 For example, the EPO stated the references 
taught a composite where the nanoparticles were made from the same 
material.149 To overcome this, the applicants amended claim 1 to 
specify the host material and nanoparticles were made from different 
 
146 APPLICANT ARGUMENTS/REMARKS MADE IN AN AMENDMENT, supra note 
124; APPLICANT ARGUMENTS/REMARKS MADE IN AN AMENDMENT supra note 
128.  
147 Reply to Communication from the Examining Division, supra note 135; 
Reply to Communication from the Examining Division, supra note 137. 
148 Id.  
149 Id.  
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materials,150  shown in Table 4. In contrast, the applicants in the US 
combined the limitation from claim 15 with claim 1, after the USPTO 
indicated claim 1 shared the same materials and properties with another 
US patent reference.151  
Ultimately, the outcomes of the applications were similar in 
both jurisdictions. Both patents issued and similar prior art sets allowed 
the applicants to make similar amendments in some respects. However, 
the US patent contains broader claims than the EU patent because the 
non-patent references cited by the EPO required the applicants to make 
additional amendments to the EU application. 
C. Case 3: US 2012/0208002 & EP 2,470,472  
On August 25, 2010, the applicants filed a PCT application 
directed to a ceramic composite material consisting of aligned 
nanotubes that improved thermal conductivity.152 The EPO conducted 
an international prior art search which published on November 10, 
2010.153 An IPR followed on February 28, 2012, and stated that each 
claim lacked an inventive step.154 On March 19, 2012, the applicants 
amended claim 9 and 14 and canceled claims 19-22.155 On June 23, 
2016, the EPO sent a notice that the application did not meet the 
patentability requirements of the EPC for the reasons stated in the 
IPR.156 On November 3, 2016, the applicants replied that the claims did 






150 Id.  
151 APPLICANT ARGUMENTS/REMARKS MADE IN AN AMENDMENT, supra note 
128.  
152 World Intellectual Property Organization (WIPO), Composite Materials 
Containing Aligned Nanotubes and the Production Thereof, WO 2011/024000 
(filed on Aug. 25, 2010). 
153 European Patent Office (EPO), International Search Report, File No. 
10752912.5 (Nov. 10, 2010). 
154 European Patent Office (EPO), International Preliminary Report on 
Patentability, File No. 10752912.5 (Feb. 28, 2012). 
155 European Patent Office (EPO), Amended Claims with Annotations, File No. 
10752912.5 (Mar. 19, 2012). 
156 European Patent Office (EPO), Communication from the Examining 
Division, File No. 10752912.5 (June 23, 2016). 




Inventive Step Argument EPO Response 
The thermal conductivity of 
the material claimed in the 
invention was significantly 
higher than that of the 
material specified in the prior 
art157 
The use of aligned nanotubes 
was in reach of the skilled 
person in light of the prior 
art158 
The references were not an 
appropriate starting point for 
assessing inventive step 
because the references were 
not concerned with the same 
technical problem as the 
invention159 
The subject matter of claims 
1-10 could be considered new 
and inventive but some 
additional objections needed 
to be overcome160 
Table 5: Applicant’s Inventive Steps Arguments and the EPO Response 
Among the additional objections that need to be overcome 
were that claim 1 was overly broad.161 The applicant’s narrowed claim 
1, and the EPO subsequently granted the patent on May 3, 2020.162  
The applicants also submitted a US patent application on May 7, 
2012.163 The USPTO required the application to be restricted to one 
invention because claims 1-9 and 11-13 were drawn to a method of 
forming the ceramic composite while claims 14-21 were drawn to the 
ceramic composite itself.164 On April 25, 2013, the applicants replied 
electing to restrict the invention to the method of forming the ceramic 
 
157 European Patent Office (EPO), Reply to Communication from the 
Examining Division, File No. 10752912.5 (Nov. 3, 2016). 
158 European Patent Office (EPO), Communication from the Examining 
Division, File No. 10752912.5 (May 10, 2017).  
159 European Patent Office (EPO), Amended Claims with Annotations, File No. 
10752912.5 (Feb. 15, 2018). 
160 European Patent Office (EPO), Result of Consultation by Telephone/in 
Person, File No. 10752912.5 (Feb. 28, 2018).  
161 Id.  
162 European Patent Office (EPO), Decision to Grant a European Patent, File 
No. 10752912.5 (May 3, 2020). 
163 U.S. Patent Application Serial No. 13/392,124 (filed May 7, 2012). 
164 Id.  
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composite.165 On August 6, 2013, the USPTO sent its first Office 
Action stating that claims 1-5, 7-9, and 11-13 were obvious in light of 
two of the prior art references.166 The applicants responded arguing the 
invention was nonobvious, shown in Table 6.  
Table 6: Applicant’s Nonobviousness Arguments and the USPTO Response 
Both arguments were rejected by the USPTO, prompting the 
applicants to submit amendments to claim 1.171 On March 1, 2016, the 
PTO sent their final Office Action stating claim 1 was obvious in light 
of new prior art.172 The next and last available document shows that in 
October 2016, the USPTO sent a notice to the applicants that they 
failed to reply to the Office Action.173  
To summarize, the EU application issued into a patent174 
whereas the US application was abandoned.175 The USPTO relied on 
 
165 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, RESPONSE TO 
ELECTION/RESTRICTION FILED (Apr. 25, 2013). 
166 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, NONFINAL 
REJECTION (Aug. 6, 2013).  
167 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, 
AMENDMENT/REQUEST FOR RECONSIDERATION AFTER NONFINAL REJECTION 
(Dec. 5, 2013). 
168 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, FINAL 
REJECTION (Dec. 23, 2013). 
169 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, APPLICANT 
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (Dec. 23, 2013).  
170 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, NONFINAL 
REJECTION (Oct. 9, 2014).  
171 FINAL REJECTION, supra note 168; NONFINAL REJECTION, supra note 170. 
172 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, FINAL 
REJECTION (Mar. 1, 2016).  
173 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, ABANDONMENT 
(Oct. 25, 2016).  
174 Decision to Grant a European Patent, supra note 162.  
175 ABANDONMENT, supra note 173.  
Nonobvious Argument PTO Response 
Fibers disclosed in the prior art 
were much larger than the 
nanotubes disclosed in the 
invention167 
The fibers in the references 
could be smaller than those 
argued by applicant168 
The invention taught dipping an 
array of nanotubes in a solution 
whereas one reference taught 
pouring a ceramic solution on 
an array169 
Applicants attacked references 
individually when the rejection 
was based on obviousness170 
2021] NANOTECHNOLOGY  359 
three US patents, three US patent applications, one foreign patent, and 
four non-patent references.176 The EPO relied on one international 
patent application and four non-patent references.177 None of the 
references relied on by the patent offices overlapped, as indicate in 
Table 8. Again, this had a big impact on the perceived validity of the 
applications.  
 
Table 8: References Cited by the USPTO178 and EPO179 
For example, both applicants amended claim 1 to specify the 
array of substantially aligned nanotubes were carbon nanotubes,180 as 
shown in Table 9. Additionally, both applicants amended claim 1 to 
specify that the ceramic matrix material is in the form of a sol.181  
 
 
176 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, LIST OF 
REFERENCES CITED BY EXAMINER (Aug. 6, 2013); U.S. PATENT & 
TRADEMARK OFFICE, FILE NO. 13392124, LIST OF REFERENCES CITED BY 
EXAMINER (Feb. 27, 2015); U.S. PATENT & TRADEMARK OFFICE, FILE NO. 
13392124, LIST OF REFERENCES CITED BY EXAMINER (Mar. 1, 2016). 
177 European Patent Office (EPO), International Search Report, File No. 
10752912.5 (Aug. 8, 2013). 
178 LIST OF REFERENCES CITED BY EXAMINER (Aug. 6, 2013), supra note 176; 
LIST OF REFERENCES CITED BY EXAMINER (Feb. 27, 2015), supra note 176; 
LIST OF REFERENCES CITED BY EXAMINER (Mar. 1, 2016), supra note 176. 
179 International Search Report, supra note 177.  
180 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, APPLICANT 
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (Feb. 9, 2015); European 
Patent Office (EPO), Reply to Communication from the Examining Division, 
File No. 10752912.5 (Sept. 19, 2019). 
181 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, APPLICANT 
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (Jan. 22, 2016); Reply to 
Communication from the Examining Division, supra note 180. 
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 EU Claim 1: Amended  US Claim 1: Amended 
A method of forming a 
composite material comprising 
nanotube oriented in a matrix 
comprising a ceramic material, 
the method comprising the 
steps of: providing an array of 
substantially aligned 
nanotubes, wherein the 
nanotubes comprise carbon 
nanotubes; providing a 
ceramic matrix material in the 
form of a solution; applying 
the solution to the nanotubes; 
allowing the solution to 
infiltrate into the array of 
nanotubes; and sintering the 
ceramic matrix material to 
form the composite material; 
wherein the nanotubes are 
substantially aligned in the 
ceramic matrix, wherein the 
ceramic matrix is formed by a 
sol-gel process.182 
A method of forming a composite 
material comprising nanotube 
oriented in a matrix comprising a 
ceramic material, the method 
comprising the steps of: providing 
an array of substantially aligned 
nanotubes, wherein the nanotubes 
are carbon nanotubes; providing a 
ceramic matrix material in the form 
of a solution; applying the solution 
to the nanotubes; allowing the 
solution to infiltrate into the array of 
nanotubes; and sintering the 
ceramic matrix material to form the 
composite material; wherein the 
nanotubes are substantially aligned 
in the ceramic matrix, wherein the 
step of applying the solution to the 
nanotubes comprises dipping the 
array of nanotubes in the solution 
and the solution infiltrates into the 
array of nanotubes by capillary 
action; wherein the solution of the 
ceramic matrix material is provided 
in the form of a sol, and wherein the 
sol is a colloidal suspension having 
a particle size of 1 to 10 nm.183 
Table 9: Amendments Made to the US and EU Applications 
However, the additional US patent material and non-patent 
references relied on by the USPTO rendered the applicant’s claims 
obvious in the eyes of the examiner.184 The US applicants did not argue 
the prior art was not analogous to the invention, which was a successful 
argument at the EPO.185 Rather, the US applicants made new 
 
182 APPLICANT ARGUMENTS/REMARKS MADE IN AN AMENDMENT (Feb. 9, 
2015), supra note 180; APPLICANT ARGUMENTS/REMARKS MADE IN AN 
AMENDMENT (Jan. 22, 2016), supra note 181.  
183 Reply to Communication from the Examining Division, supra note 180. 
184 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, FINAL 
REJECTION (Mar. 1, 2016). 
185 Amended Claims with Annotations, supra note 159.  
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arguments and amendments without countering the points made by the 
examiner—a strategy that was ineffective.186  
Ultimately, the applicants made similar amendments during 
prosecution, but the different prior art relied on by the patent offices 
and nonobvious arguments made by the applicants resulted in different 
outcomes for the applications. In this case, the patent and non-patent 
references relied on by the USPTO prevented the US applicants from 
successfully amending their claims, as the applicants did in the EU.  
D. Case 4: US 6,346,189 & WO 00/09443 
US Patent 6,346,189 was one of the “building block” patents187 
and described “Carbon Nanotube Structures Made Using Catalyst 
Islands.”188 The US patent issued before the USPTO began publishing 
prosecution history, so it was not possible to compare the US 
prosecution with the EU prosecution. However, the European 
prosecution history was published and revealed the application was 
abandoned.189 Previous scholars would suggest the EPO’s investment 
in getting patent quality right at early stages of prosecution gave the 
applicant a good indication of the likely outcome of their application.190 
In this case, the international prior art search found a US patent and 
two international patent applications, listed in Table 10, that were 
relevant to every claim in the patent.191  
 
Table 10: References Cited by the EPO192 
 
186 U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, APPLICANT 
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (July 27, 2015); U.S. 
PATENT & TRADEMARK OFFICE, FILE NO. 13392124, APPLICANT 
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (Jan. 22, 2016). 
187 Lemley, supra note 15, at 613. 
188 U.S. Patent No. 6,346,189.  
189 European Patent Office (EPO), Matter Concerning the Application, File 
No. 99932269.6 (Sept. 17, 2001). 
190 See Chien, supra note 12, at 107. 
191 European Patent Office (EPO), Copy of the International Search Report, 
File No. 99932269.2 (Oct. 21, 1999). 
192 Id.  
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Notably, each of references in the international prior art search 
are also cited as references in the US patent.193 Without analyzing the 
US prosecution, it is not clear whether the references affected the 
outcome of the prosecution. It is possible the references were included 
in the US patent without affecting the scope of the claims, like in the 
previous nanotechnology patent study.194 
CONCLUSION 
The results from the three case studies largely confirm the 
prediction that US nano patent applications would issue into patents at 
a higher rate than the European Applications. In one study, the EPO 
relied on different prior art references than the USPTO and indicated 
to the applicants early that every claim in the application lacked novelty 
and an inventive step.195 Also as predicted, the EU patents contained 
narrower claims.196 While the patent offices relied on several common 
references, the unique references found by the EPO forced additional 
amendments in the EU applications.197 This could be explained by the 
EPO’s reputation as a better patent office.198 It follows that if the EPO 
applies more examiners and time to each application, one result would 
be higher quality prior art references. With this in mind, 
nanotechnology companies should be prepared for different treatment 
at the EPO than at the USPTO, and, where applications issue into 
patents,  different patent scopes. 
 
193 ’189 Patent at [56]. 
194 Escoffier, supra note 45, at 29.  
195 See discussion supra Section IV.A.  
196 See supra Table 4.  
197 See Reply to Communication from the Examining Division, supra note 137. 
198 Chien, supra note 12, at 74.  
